LONDON, November 22, 2013 /PRNewswire/ --
On Thursday, November 21, 2013, all three indexes of the US equity market rose. The S&P 500 ended the day at 1,795.85, up 0.81%; the Dow Jones Industrial Average closed at 16,009.99, up 0.69%; and the NASDAQ Composite finished at 3,969.16, up 1.22%. Shares in the medical laboratories and research industry ended on a positive note, tracking gains in the broader market. The major movers in the industry included Organovo Holdings Inc. (NYSE MKT: ONVO), Agilent Technologies Inc. (NYSE: A), Thermo Fisher Scientific Inc. (NYSE: TMO), and Laboratory Corp of America Holdings (NYSE: LH). AAAResearchReports.com has released free charting and technical research on these aforementioned companies. Register to read these reports at:
On Thursday, Organovo Holdings Inc.'s stock rallied 11.45%, tracking gains in the broader market. The company's shares oscillated between $8.13 and $9.72 before closing the day at $8.86. A total of 15.23 million shares were traded, which is above the daily average volume of 4.52 million. The company's shares have rallied 51.19% in the previous three months and 42.44% in the last one month, outperforming the S&P 500, which has gained 9.32% and 2.93% during the respective periods. Furthermore, Organovo Holdings Inc.'s stock is trading above its 50-day and 200-day moving averages of $6.95 and $5.19, respectively. Sign up for free report on ONVO at:
Agilent Technologies Inc.'s stock posted gains on Thursday, ending the day at $54.10 which is 1.06% higher than the previous day's closing price of $53.53. The company's shares oscillated between $53.70 and $54.55 during the trading session. A total of 2.42 million shares were traded, which is below the daily average volume of 2.66 million. Agilent Technologies Inc.'s shares have gained 15.38% in the previous three months and 4.06% in the last one month, outperforming the S&P 500, which has gained 9.32% and 2.93% during the respective periods. Moreover, the company's stock is trading above its 50-day and 200-day-moving averages of $51.29 and $45.99, respectively. A free technical report can be accessed by signing up at:
Thermo Fisher Scientific Inc.'s stock advanced on Thursday, hitting a new 52-week high of $103.12. The company's shares closed the day 0.74% higher at $101.82, after vacillating between $101.33 and $103.12 during the trading session. A total of 1.32 million shares were traded, which is below the daily average volume of 1.48 million. The company's shares have gained 6.90% in the last one month and 13.05% in the previous three months, compared to a gain of 2.93% and 9.32% in the S&P 500 during the respective periods. Further, Thermo Fisher Scientific Inc.'s stock is trading above its 50-day and 200-day moving averages of $95.22 and $86.54, respectively. A free report on TMO can be accessed by registering at:
Shares in Laboratory Corp of America Holdings edged higher on Thursday, tracking gains in the US equity market. The company's shares closed the day at $104.83, up 0.65%, after oscillating between $104.15 and $104.96 during the trading session. A total of 0.47 million shares were traded, which is below the daily average volume of 0.61 million. The company's shares have advanced 5.55% in the previous one month, outperforming the S&P 500, which has advanced 2.93% during the same period. Furthermore, Laboratory Corp of America Holdings' stock is trading above its 50-day and 200-day moving averages of $101.35 and $96.77, respectively. Register with AAA Research Reports and download research on LH for free at:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
- For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE AAA Research Reports